Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.72
-0.1900-3.87%
Post-market: 4.65-0.0700-1.48%18:02 EDT
Volume:569.02K
Turnover:2.69M
Market Cap:147.69M
PE:-1.14
High:4.88
Open:4.85
Low:4.68
Close:4.91
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:0.78
T/O Rate:3.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.67
PE(LYR):-1.66

Loading ...

Electra Therapeutics Files for IPO

Dow Jones
·
Aug 29

Alterity Therapeutics Reaffirmed at Buy as Pivotal Phase 3 Nears; $16 Price Target Maintained

TIPRANKS
·
Aug 29

Aprea Therapeutics Expands Global IP for Precision Oncology

TIPRANKS
·
Aug 28

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

GlobeNewswire
·
Aug 28

Kazia Therapeutics 2.58M share Spot Secondary priced at $15.50

TIPRANKS
·
Aug 28

BioXcel Therapeutics Initiates Chapter 11 and Sale Process

TIPRANKS
·
Aug 28

Kazia Therapeutics Cuts ATM Offering Capacity to $80 Million

TIPRANKS
·
Aug 28

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

GlobeNewswire
·
Aug 28

PYC Therapeutics Files 2026 Corporate Governance Statement with ASX

TIPRANKS
·
Aug 28

PYC Therapeutics Details Governance and Operations in 2026 Annual Report

TIPRANKS
·
Aug 28

PYC Therapeutics Narrows Loss and Strengthens Balance Sheet in FY2026

TIPRANKS
·
Aug 28

Alterity Therapeutics Files Updated Corporate Governance Statement with ASX

TIPRANKS
·
Aug 28

Alterity Therapeutics Doubles Annual Loss as It Ramps Up Neurodegeneration R&D

TIPRANKS
·
Aug 28

Amplia Therapeutics Highlights Strong Pancreatic Cancer Data in AGM CEO Presentation

TIPRANKS
·
Aug 28

Kazia Therapeutics Posts 100% Clinical Benefit in Early Triple-Negative Breast Cancer Paxalisib Study

TIPRANKS
·
Aug 28

Quince Therapeutics Announces Planned Presidential Leadership Transition

TIPRANKS
·
Aug 28

Rein Therapeutics Receives Nasdaq Delisting Notice Over Bid Price

TIPRANKS
·
Aug 28

ADRs Close Higher; Kazia Therapeutics Ltd. Climbs 16%

Dow Jones
·
Aug 28

Kazia Therapeutics reports 100% clinical benefit rate in breast cancer treatment

TIPRANKS
·
Aug 28

Kazia Therapeutics announces offering of ADS, warrants

TIPRANKS
·
Aug 28